Empagliflozin/linagliptin Empagliflozin/metformin Empagliflozin SGLT2 inhibitor Canagliflozin/metformin Colin Baigent Bernard Zinman Dapagliflozin/metformin Sodium-glucose transport proteins Dapagliflozin Linagliptin Discovery and development of gliflozins Canagliflozin Diabetes medication Stefan D. Anker Boehringer Ingelheim Christos Socrates Mantzoros Vildagliptin/metformin Dapagliflozin/saxagliptin/metformin Dapagliflozin/saxagliptin Pioglitazone/glimepiride Ertugliflozin Insulin glargine Sitagliptin/metformin Insulin aspart Insulin icodec Insulin degludec/insulin aspart Albiglutide Insulin degludec/liraglutide Benfluorex Metformin Retatrutide Insulin lispro Insulin glulisine Vi…

ildagliptin Lixisenatide Sotagliflozin Rosiglitazone Insulin detemir Janagliflozin Insulin glargine/lixisenatide Dasiglucagon Saxagliptin Liraglutide Semaglutide Diabetic nephropathy Mizagliflozin Pioglitazone Tirzepatide Pioglitazone/metformin Insulin degludec Dulaglutide Insulin analog Exenatide Saroglitazar Ranirestat Omarigliptin Ipragliflozin Alogliptin Gliclazide Lente insulin Dipeptidyl peptidase-4 inhibitor Troglitazone Sitagliptin Thiazolidinedione Acarbose Tolbutamide Bromocriptine Buformin GLP-1 receptor agonist Sodium/glucose cotransporter 1 Insulin (medication)